The primary objective of this study is to assess the safety and performance of the ABLE Daily to perform ambulatory functions in home and community settings for people with spinal cord injury.The secondary objectives are to assess the impact of the…
ID
Source
Brief title
Condition
- Spinal cord and nerve root disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary objective of this study is to confirm the safety and performance of
the ABLE Daily to perform ambulatory functions in home and community settings
for people with spinal cord injury.
Secondary outcome
The secondary objectives are to assess the impact of the ABLE Daily use on the
perceived general health of the participants, the gait performance with the
ABLE Daily using data collected from the exoskeleton, and the level of user
satisfaction from participants, companions, and therapists.
Background summary
A spinal cord injury can affect the patients' ability to walk and maintain
balance. As a result, paraplegic patients are often dependent on the wheelchair
to move around, which means they sit a lot during the day. This results in less
physical movement each day, which might have negative consequences for the
mental and physical health.
With the emerging technologies, an exoskeleton could perhaps (partly) replace
the wheelchair and increase the amount of physical movement in a day. At the
moment, exoskeletons are only used in clinics and not yet in the home
environment. To date, only one study has been published that has investigated
the effect of home use the Rewalk exoskeleton. This research has shown
improvements on the mental and physical health in spinal cord injury patients
after only two weeks of using an exoskeleton in the home environment, but it is
still unknown what the consequences are for mental and physical health after an
installed period in the home environment .
Study objective
The primary objective of this study is to assess the safety and performance of
the ABLE Daily to perform ambulatory functions in home and community settings
for people with spinal cord injury.
The secondary objectives are to assess the impact of the ABLE Daily use on the
perceived general health of the participants, the gait performance with the
ABLE Daily using data collected from the exoskeleton, and the level of user
satisfaction from participants, companions, and therapists.
Additionally, exploratory endpoints are selected to observe the effect of using
the ABLE Daily for ambulatory functions in home and community settings on
health promotion. The change from baseline to final assessment of participant*s
parameters in the following domains will be quantified:
- Cardiovascular
- Respiratory
- Muscle spasms and spasticity
- Bowel function
- Bladder function
- Body composition
- Insulin sensitivity
- Sleep quality
- Mental health and quality of life
Study design
Intervention study with 10 spinal cord injury patients.
Intervention
ABLE Daily exoskeleton use in the home and community settings.
Study burden and risks
The research is quite time-intensive. We ask the participant to practice with
the exoskeleton in the clinic three times a week during the clinical period of
three weeks. Once the participants have received the exoskeleton home, we
expect them to walk with the exoskeleton at least three times a week for 30
minutes.
The exoskeleton can create pressure points on the skin. In addition to the
pressure points, the participant may experience joint pain or swelling because
the participant is moved by the exoskeleton or because the exoskeleton has not
been fitted properly. To reduce the risk of pressure points and joint pain or
swelling, the skin will be examined before and after training by the therapist
and at home by the buddy. In addition, the ABLE Daily has cushions at the
various contact points.
When the participant moves from sitting position to standing position, a sudden
difference in blood pressure can cause dizziness. This physical response is
reduced when this movement is repeated more often.
Because the participant is not used to walking in an exoskeleton, the
participant can easily lose balance. The participant is therefore required to
use crutches or a walker that help maintain balance. In addition, the buddy
must always be present when the exoskeleton is used. Despite these measures,
there is still a chance that the participant will fall.
Previous research has shown that in rare cases bone fractures occur due to the
use of the exoskeleton. In this study, there will be a preliminary screening to
confirm that the participants have healthy, strong bones. Despite this measure,
it cannot be ruled out that there is a risk of bone fractures during this
study.
Exoskeletons could be suitable for improving the mobility and independence of
people with physical disabilities. Previous research with a different
exoskeleton has shown that there may be health benefits to walking with an
exoskeleton. Reduced spasticity in the muscles was observed, less pain,
improved bowel function, improved fitness and less fatigue and thus an improved
quality of life. However, we cannot guarantee that participants will experience
these benefits. By participating in the study, we can gain more knowledge about
the application of the exoskeleton in rehabilitation, which could possibly help
people who are in a similar situation as the participant.
Hengstdal 3
Ubbergen 6574NA
NL
Hengstdal 3
Ubbergen 6574NA
NL
Listed location countries
Age
Inclusion criteria
At least 18 years old
Chronic SCI (>6 months)
Injury at levels T1 to L5 (AIS A to D)
Walking Index Spinal Cord Injury (WISCII) 0 till 9
Between 150-200 cm
Weight less than 100 kilograms
Capable of giving informed consent on their own
Able to train (at least) 3 days/week
Able to have at least 1 companion/buddy who can attend a minimum of two of the
training sessions, besides the Final assessment, and who will learn how to
assist them at home and in the community. (ideally two companions)
Proficiency in walking with the ABLE Exoskeleton
At least 8 weeks with minimal use (less than 5 sessions) of wearable robotic
exoskeletons for gait assistance at the start of the study.
Exclusion criteria
High risk of fractures due to osteoporosis, a dual energy X-ray absorptiometry
(DEXA)-scan at the hip, distal femur and proximal tibia T-score < -2.5 or BMD
smaller/equal to 0.78 g/cm^2
Fragility fractures of the lower limbs in the last 2 years
Deterioration >3 in the International Standards for Neurological Classification
of SCI (ISNCSCI) score in the last 4 weeks
Spinal instability, like spondylolisthesis
Disorders of the arms and hands that make walking with crutches impossible
Modified Ashworth Scale (MAS) >3 in lower limbs
Cardiovascular health issues which prevent the participant from training
Inability to tolerate 10 minutes of standing without clinical symptoms of
orthostatic hypotension
Psychological, cognitive issues, or any other condition that does not allow a
participant to follow study procedures
Medically unstable due to severe comorbidities, including any condition that a
physician deems inappropriate for completing study participation
Skin problems in areas that would be in contact with the device
Height, width, weight, or other anatomical limitations (such as differences in
leg length) incompatible with the device
Insufficient joint range of motion (ROM) for the device
Known pregnancy
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL88507.000.24 |